MMWR Morb Mortal Wkly Rep. 2010 Mar 5;59(8):230-3.
Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and pneumonia in children aged <1 year worldwide. Each year in the United States, an estimated 75,000-125,000 infants are hospitalized with RSV. Among adults aged >65 years, an estimated 177,000 hospitalizations and 14,000 deaths a year have been attributed to RSV infections. In temperate climates, the RSV season generally begins during the fall and continues through the winter and spring, but the exact timing of RSV circulation varies by location and year. In the United States, data from the National Respiratory and Enteric Virus Surveillance System (NREVSS) are used to monitor the seasonal occurrence of RSV. During the 2008-09 season, onset occurred from mid-October to late December in the 10 U.S. Department of Health and Human Services (HHS) regions, excluding Florida, which had onset in mid-July. Season offset in all regions occurred from mid-February to mid-April. Florida is reported separately because it has an earlier season onset and longer duration than the rest of the country. During the current 2009-10 season, onset occurred in all 10 HHS regions by February 20, 2010. These patterns are similar to previous years and confirm differences in RSV seasonal characteristics across regions. Knowledge of RSV seasonality can be used by clinicians and public health officials to determine when to consider RSV as a cause of acute respiratory illnesses and when to provide RSV immunoprophylaxis to children at high risk for serious disease.
呼吸道合胞病毒(RSV)是全球 1 岁以下儿童毛细支气管炎和肺炎的最常见病因。据估计,每年在美国有 7.5 万至 12.5 万名婴儿因 RSV 住院。在 65 岁以上的成年人中,每年估计有 17.7 万人因 RSV 感染住院,14000 人死亡。在温带气候中,RSV 季节通常始于秋季,持续到冬季和春季,但 RSV 流行的确切时间因地点和年份而异。在美国,国家呼吸道和肠道病毒监测系统(NREVSS)的数据用于监测 RSV 的季节性发生情况。在 2008-09 季节,10 个美国卫生与公众服务部(HHS)地区的发病时间从中 10 月中旬到 12 月底,佛罗里达州除外,其发病时间为 7 月中旬。所有地区的发病时间从中 2 月中旬到 4 月中旬。佛罗里达州单独报告,因为它的发病时间早于全国其他地区,持续时间也长于全国其他地区。在当前 2009-10 季节,到 2010 年 2 月 20 日,10 个 HHS 地区都出现了发病。这些模式与前几年相似,证实了 RSV 季节性特征在不同地区存在差异。了解 RSV 的季节性有助于临床医生和公共卫生官员确定何时考虑 RSV 是急性呼吸道疾病的病因,以及何时向高危儿童提供 RSV 免疫预防。